These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37629039)

  • 1. Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options.
    Laukaitiene J; Gujyte G; Kadusevicius E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment.
    Zhang T; Deng W; Deng Y; Liu Y; Xiao S; Luo Y; Xiang W; He Q
    Biomed Pharmacother; 2023 Sep; 165():114706. PubMed ID: 37400352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into myocardial ischemia-reperfusion injury from the perspective of ferroptosis.
    Huang X; Wang Y; Cui X; Yan Q; Xue T; Jing X
    Perfusion; 2024 Sep; ():2676591241280371. PubMed ID: 39264884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ferroptosis in myocardial ischemia/reperfusion model of rat and its association with Sestrin 1.
    Yang F; Wang W; Zhang Y; Nong J; Zhang L
    Adv Clin Exp Med; 2023 Feb; 32(2):219-231. PubMed ID: 36413176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis.
    Li JY; Liu SQ; Yao RQ; Tian YP; Yao YM
    Front Cell Dev Biol; 2021; 9():799499. PubMed ID: 34926476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.
    Zhang CH; Yan YJ; Luo Q
    Life Sci; 2024 Mar; 340():122439. PubMed ID: 38278348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.
    Baba Y; Higa JK; Shimada BK; Horiuchi KM; Suhara T; Kobayashi M; Woo JD; Aoyagi H; Marh KS; Kitaoka H; Matsui T
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H659-H668. PubMed ID: 29127238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid oxidation products in ferroptotic myocardial cell death.
    Stamenkovic A; Pierce GN; Ravandi A
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H156-H163. PubMed ID: 31050558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis.
    Cai W; Liu L; Shi X; Liu Y; Wang J; Fang X; Chen Z; Ai D; Zhu Y; Zhang X
    Circulation; 2023 May; 147(19):1444-1460. PubMed ID: 36987924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation, ferroptosis, and their potential relationships: Implications in myocardial ischemia-reperfusion injury.
    Yang Y; Ma M; Su J; Jia L; Zhang D; Lin X
    Am J Med Sci; 2023 Sep; 366(3):176-184. PubMed ID: 37290744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-199a-5p promotes ferroptosis-induced cardiomyocyte death responding to oxygen-glucose deprivation/reperfusion injury via inhibiting Akt/eNOS signaling pathway.
    Zhang GY; Gao Y; Guo XY; Wang GH; Guo CX
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1093-1102. PubMed ID: 36254861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries.
    Han X; Zhang J; Liu J; Wang H; Du F; Zeng X; Guo C
    Apoptosis; 2023 Feb; 28(1-2):108-123. PubMed ID: 36474078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.
    Zhao WK; Zhou Y; Xu TT; Wu Q
    Oxid Med Cell Longev; 2021; 2021():9929687. PubMed ID: 34725566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A-loaded apoferritin alleviates myocardial ischemia-reperfusion injury by simultaneously blocking ferroptosis and apoptosis of cardiomyocytes.
    Qian W; Liu D; Han Y; Liu M; Liu B; Ji Q; Zhang B; Mei Q; Zhou S; Cheng Y
    Acta Biomater; 2023 Apr; 160():265-280. PubMed ID: 36822483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis as a novel therapeutic target for cardiovascular disease.
    Wu X; Li Y; Zhang S; Zhou X
    Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.
    Fang X; Ardehali H; Min J; Wang F
    Nat Rev Cardiol; 2023 Jan; 20(1):7-23. PubMed ID: 35788564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Roles of Iron in Cardiovascular Disease.
    Kobayashi M; Suhara T; Baba Y; Kawasaki NK; Higa JK; Matsui T
    Curr Drug Targets; 2018; 19(9):1068-1076. PubMed ID: 29874997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.